抗体免疫与隐球菌抗原血症及死亡率的关联:南非晚期人类免疫缺陷病毒感染队列研究
研究纳入197名接受隐球菌抗原筛查的南非HIV感染者,随访6个月,检测血中隐球菌荚膜多糖葡糖醛酸木甘露聚糖(GXM)及β-葡聚糖结合抗体。CrAg阳性者GXM-IgG较高、curdlan-IgG较低;GXM-IgG与抗原血症正相关(OR 1.64),在CrAg阳性者中与6个月死亡率负相关(HR 0.50)。
要点
- CrAg阳性者GXM-IgG中位滴度1:170,高于CrAg阴性者的1:117(P=.0009)。
- GXM-IgG与隐球菌抗原血症独立正相关,校正CD4和ART后OR 1.64(95%CI 1.21–2.22)。
- CrAg阳性者中GXM-IgG与6个月死亡率负相关,校正CD4和结核后HR 0.50(95%CI .33–.77)。
核心结论
- CrAg阳性个体中GXM-IgG与死亡率的负相关提示GXM-IgG滴度可能具有预后价值。
- 作者认为需要前瞻性纵向研究验证该假设并探究抗体保护机制。
研究设计与样本
- 研究纳入197名接受CrAg筛查的南非HIV感染者,随访至6个月。
- 检测血中GXM结合抗体及天然β-葡聚糖(laminarin、curdlan)结合抗体。
- 采用logistic回归和Cox回归分析抗体滴度与CrAg状态及全因死亡率的关系。
主要发现
- CrAg阳性者(n=67)较CrAg阴性者(n=130)IgG1中位6672 μg/mL(IQR 4696–10414)vs 5343 μg/mL(IQR 3808–7722),P=.007。
- CrAg阳性者IgG2中位1467 μg/mL(IQR 813–2607)vs 1036 μg/mL(IQR 519–2012),P=.01。
- CrAg阳性者GXM-IgG中位1:170(IQR 61–412)vs 1:117(IQR 47–176),P=.0009。
- CrAg阳性者curdlan-IgG中位1:47(IQR 11–133)vs 1:93(IQR 40–206),P=.01。
- 校正CD4和抗逆转录病毒治疗后,GXM-IgG与隐球菌抗原血症正相关,OR 1.64(95%CI 1.21–2.22)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Asymptomatic cryptococcal antigenemia (positive blood cryptococcal antigen [CrAg]) is associated with increased mortality in individuals with human immunodeficiency virus (HIV) even after adjusting for CD4 count and despite receiving antifungal treatment. The association of antibody immunity with mortality in adults with HIV with cryptococcal antigenemia is unknown. METHODS: Cryptococcal capsular glucuronoxylomannan (GXM)- and naturally occurring β-glucans (laminarin, curdlan)-binding antibodies were measured in blood samples of 197 South Africans with HIV who underwent CrAg screening and were followed up to 6 months. Associations between antibody titers, CrAg status, and all-cause mortality were sought using logistic and Cox regression, respectively. RESULTS: Compared with CrAg-negative individuals (n = 130), CrAg-positive individuals (n = 67) had significantly higher IgG1 (median, 6672; interquartile range [IQR], 4696-10 414 vs 5343, 3808-7722 μg/mL; P = .007), IgG2 (1467, 813-2607 vs 1036, 519-2012 μg/mL; P = .01), and GXM-IgG (1:170, 61-412 vs 1:117, 47-176; P = .0009) and lower curdlan-IgG (1:47, 11-133 vs 1:93, 40-206; P = .01) titers. GXM-IgG was associated directly with cryptococcal antigenemia adjusted for CD4 count and antiretroviral therapy use (odds ratio, 1.64; 95% confidence interval [CI], 1.21 to 2.22). Among CrAg-positive individuals, GXM-IgG was inversely associated with mortality at 6 months adjusted for CD4 count and tuberculosis (hazard ratio, 0.50; 95% CI, .33 to .77). CONCLUSIONS: The inverse association of GXM-IgG with mortality in CrAg-positive individuals suggests that GXM-IgG titer may have prognostic value in those individuals. Prospective longitudinal studies to investigate this hypothesis and identify mechanisms by which antibody may protect against mortality are warranted.
引用
- Yoon H, Wake RM, Nakouzi AS, et al. Association of Antibody Immunity With Cryptococcal Antigenemia and Mortality in a South African Cohort With Advanced Human Immunodeficiency Virus Disease. Clin Infect Dis. 2023. PMID: 35915964. doi:10.1093/cid/ciac633
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。